1. Conclusions Bilirubinemia is a common complication after liver transplantation and its reasons and mechanism are complicated.

2. Objective To judge the intervening project's implementing effect of neonatal hyper-unconjugated bilirubinemia in early days.

3. Objective To investigate the occurring rule and characteristics of bilirubinemia after liver transplantation to improve proper rate of differential diagnosis and treatment.

4. Objective To evaluate the clinical effect of Mamiai on neonatal bilirubinemia.

5. Conclusion: The early synthesis intervention implementation to the premature infant, may prevent the high bilirubinemia sickness occurrence and reduce the high bilirubinemia sickness degree.

6. Objective: To explore the most effective ways of preventing early the premature infant high bilirubinemia sickness.